Results 31 to 40 of about 148,322 (271)

Consumer-Directed Health Care: Can Consumers Look After Themselves? [PDF]

open access: yes, 2008
In health care systems today, including those of Switzerland and the United States, participants do not necessarily see the big picture of lifetime health costs and quality of life, and in many systems consumers and providers lack the incentives to ...
Heiss, Florian   +2 more
core   +2 more sources

High Health Care Utilization Preceding Diagnosis With Juvenile Idiopathic Arthritis

open access: yesArthritis Care &Research, EarlyView.
Objective Although early diagnosis improves long‐term outcomes, patients with juvenile idiopathic arthritis (JIA) often experience prolonged, circuitous paths to diagnosis. To inform diagnostic improvement, we sought to characterize health care utilization in the year preceding diagnosis. Methods We identified 10,021 patients with an incident diagnosis
Anna Costello   +5 more
wiley   +1 more source

Real‐World Longitudinal Data on the Impact of Hydroxychloroquine Blood Level Monitoring on Lupus Outcomes: Results of a Prospective Longitudinal Cohort Study

open access: yesArthritis Care &Research, EarlyView.
Objective Hydroxychloroquine (HCQ) is a cornerstone therapy in systemic lupus erythematosus (SLE), but the weight‐based dosing does not account for clinical factors that can introduce individual variability in drug metabolism and clearance. We leveraged longitudinal data from a prospective SLE cohort to identify clinical factors that predict ...
Jay J. Patel   +6 more
wiley   +1 more source

Controlling Costs and Increasing Access to Prescription Drugs: State and Federal Solutions [PDF]

open access: yes, 2002
Spending on health care in the United States continues to increase rapidly, consuming a greater share of the total economy each year. Over the past decade, prescription drug spending has been the fastest growing component of health care expenditures both
Michael Sullivan, Rebecca Kavoussi
core  

Safety of Prescription Nonsteroidal Anti‐inflammatory Drugs in Adults With Inflammatory Bowel Disease: Data From a Large Administrative Claims Cohort

open access: yesArthritis Care &Research, EarlyView.
Objective The concern that nonsteroidal anti‐inflammatory drugs (NSAIDs) may precipitate flares of inflammatory bowel disease (IBD) has limited their use in managing musculoskeletal symptoms in those with IBD, but safety data are mixed. Methods This retrospective cohort study included patients with IBD aged at least 18 years from Optum's deidentified ...
Adam S. Mayer   +4 more
wiley   +1 more source

Ademetionine treatment cost analysis of patients with intrahepatic cholestasis and non-alcoholic fatty disease

open access: yesКачественная клиническая практика, 2022
Relevance. Ademetionine is a hepatoprotective drug, is included in the  draft Russian clinical guidelines for the  diagnosis and treatment of non-alcoholic fatty liver disease (NAFLD) and in the  clinical guidelines for treating intrahepatic cholestasis (
M. V. Zhuravleva   +6 more
doaj   +1 more source

Perceived Impacts and Predictors of Cannabis Products used by Rheumatology Patients in Alberta: A Multivariable Analysis of Cross‐sectional Survey Data

open access: yesArthritis Care &Research, Accepted Article.
Objective This study aimed to characterize cannabis product choices (cannabinoid content and formulation) among rheumatology patients, and their associations with patient factors, patient reported perceived side effects and positive impacts. Methods An online survey (delivered from March to November 2022) was distributed by Alberta Health Services to ...
Susan Zhang   +10 more
wiley   +1 more source

Pricing Dynamics in the US Hemp Market: A Vertical Price Transmission Analysis of the Hemp Value Chain

open access: yesAgribusiness, EarlyView.
ABSTRACT The US hemp market is a new and nascent industry that has been devoid of research for about half a century. This study examined the effects of exogenous shock on price at each phase of the value chain—Farm (hemp biomass), and its impact on prices at other phases of the value chain—Intermediary Processor (crude cannabidiol hemp) and Final ...
Solomon Odiase   +2 more
wiley   +1 more source

Directions of Changes in Health Care

open access: yesProblemy Zarządzania, 2017
European societies, including Poland, are aging, and this increases the demand for health spending. The prices of new medicines and medical technologies will also increase.
Henryk Mruk
doaj   +1 more source

Health Care Opinion Leaders' Views on Medicare Reform [PDF]

open access: yes, 2009
Presents findings of a survey of experts on Medicare's successes and proposed reforms, including putting payment pilots on a fast track, negotiating drug prices, and creating an advisory council with authority to make payment and benefit design ...
Karen Davis   +2 more
core  

Home - About - Disclaimer - Privacy